Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

cyclopia sequence 8Neoplasms, Plasma Cell 2Multiple Myeloma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Hypesthesia 1Head and Neck Neoplasms 1Exanthema 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Anxiety Disorders 1Acute Pain 1

Interventions

Carboplatin 195Cisplatin 117Paclitaxel 107Pemetrexed 106Docetaxel 96Gemcitabine 89Radiotherapy 83Erlotinib Hydrochloride 58Bevacizumab 55Etoposide 49durvalumab 39pembrolizumab 38Nivolumab 31Specimen Handling 30Magnetic Resonance Spectroscopy 30Irinotecan 27Radiosurgery 26osimertinib 24Gefitinib 24Drug Therapy 23Vinorelbine 22atezolizumab 20Topotecan 20Radiation 16Cetuximab 16Taxes 15Surgical Procedures, Operative 14Neoadjuvant Therapy 13Filgrastim 13Chemotherapy, Adjuvant 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Lung Neoplasms × Minocycline × Clear all
NCT01636934 2020-07-17

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy

M.D. Anderson Cancer Center

Phase 2 Completed
51 enrolled 8 charts
Thoracic

cyclopia sequence, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00473083 2017-04-04

LUTRAERL

British Columbia Cancer Agency

Phase 2 Completed
150 enrolled 13 charts
Thoracic

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡